elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Pricing
Log in
Sign up
Home
/
Subjects
/
Epidermal growth factor receptor
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Epidermal growth factor receptor
RIS
0.001
(Research Intensity Score)
Papers
151
Top papers
Osimertinib with or without Chemotherapy in EGFR -Mutated Advanced NSCLC
2023 · 681 citations
Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR –Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer
2024 · 151 citations
Amivantamab in EGFR Exon 20 Insertion–Mutated Non–Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study
2021 · 640 citations
Neoadjuvant Osimertinib for Resectable EGFR -Mutated Non–Small Cell Lung Cancer
2025 · 74 citations
Surface Functionalization of Nanocarriers with Anti-EGFR Ligands for Cancer Active Targeting
2025 · 57 citations
Systemic Therapy for Locally Advanced and Metastatic Non–Small Cell Lung Cancer
2019 · 1112 citations
Sacituzumab tirumotecan versus docetaxel for previously treated EGFR -mutated advanced non-small cell lung cancer: multicentre, open label, randomised controlled trial
2025 · 42 citations
Synthesis of Sorafenib−Ruthenium Complexes, Investigation of Biological Activities and Applications in Drug Delivery Systems as an Anticancer Agent
2024 · 51 citations
Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial
2020 · 280 citations
Newest papers
Targeted Therapy or Chemotherapy First? A Meta-Analysis in Resectable EGFR-Mutant Non-Small Cell Lung Cancer
2026
Global pharmacovigilance analysis of dermatologic toxicity in EGFR-TKI–treated NSCLC: a cross-database real-world study
2026
Targeted Therapy or Chemotherapy First? A Meta-Analysis in Resectable EGFR-Mutant Non-Small Cell Lung Cancer
2026
Targeted Therapy or Chemotherapy First? A Meta-Analysis in Resectable EGFR-Mutant Non-Small Cell Lung Cancer
2026
Editorial: EGFR-targeted therapy in lung cancer: unraveling molecular regulation, overcoming resistance, and advancing precision clinical practice
2026
Sitravatinib combined with osimertinib overcomes acquired osimertinib resistance in NSCLC by targeting AXL and the PI3K/AKT/GSK3β signaling pathway
2026
A Transgenic mouse tolerant to syngeneic cancer cells expressing truncated human epidermal growth factor receptor
2026
Acupuncture-associated gastric mucosal repair and the EGF–EGFR-related signaling network: evidence, limitations, and prospects
2026
Fabrication of electrochemical biosensor with a CD36 aptamer and AuMoS2 heterolayer for tumor-derived exosome detection
2026 · 2 citations
Browse all papers →
Epidermal growth factor receptor's history
Research intensity over time
Yearly
Personal members see monthly resolution →
Data temporarily unavailable — please try again shortly.
Close ✕
Epidermal growth factor receptor's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link